23rd April 2020
Device helps to protect dentists and their patients from infections like COVID-19
Astradentium, a former start-up supported by EIT Health’s Headstart programme, has ramped up production of its innovation to help protect dentists and their patients from aerosol-borne infections, including the virus that causes COVID-19.
Despite standard disinfection procedures, a dentist’s chair poses the risk of cross contamination between the dentist and patient, from bacteria, viruses and other pathogens present in saliva, blood and oral surfaces. Víctor Lloro, a Spanish dentist, and his brother Ivan Lloro, a space engineer, created a filter that prevents suspended microparticles, droplets and contaminated aerosols created in any standard dental procedure, from contaminating the dental office work area.
OBF Oral BioFilter is worn on the patients’ mouth and is integrated into the standard dental suction. It generates an air curtain to prevent microparticles from hanging in the air. It is therefore able to prevent cross contamination, even from oral sprays.
The demand for protection against aerosol-borne infections has increased with the onset of COVID-19, and after selling more than 100,000 units in Europe and the Americas, the company is ramping up production, according to Ivan Lloro.
“I would like to express our gratitude to EIT Health’s vision for supporting a product like the OBF as well as helping transitioning Astradentium Health Technologies from start-up status to a full fledged exporting company,” said Ivan Lloro.
Find out more here: https://www.astradentium.com
Philips ultrasound OK'd for COVID-19 lung, cardiac care
FDA approves use of firm's ultrasound portfolio to manage COVID-19-related complications
Backed by EIT Health Alumni, DAP aids care facilities
Digital Aid Project seeks to aid nursing homes, rehabilitation centres and mental health facilities
AstraZeneca to cooperate on Oxford's vaccine effort
Firm ready to facilitate distribution of Oxford University team's vaccination, which is already undergoing trials